Mary M. Horowitz

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 35 papers. Top paper: “Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial”.

Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial

Blood(2020)10.1182/blood.2020007535

N/A

5.3DataRank · unranked

212 citations

Paul V. O’Donnell, Mary Eapen, Brent R. Logan, Joseph H. Antin, Peter Dawson +12 more

Health-Related Quality of Life in Double Umbilical Cord Blood versus Haploidentical Marrow Transplantation: A Quality of Life Analysis Report of BMT CTN 1101

Transplantation and Cellular Therapy(2023)10.1016/j.jtct.2023.04.009

N/A

0.438DataRank · unranked

7 citations

Michael J. Martens, Claudio G. Brunstein, Paul V. O’Donnell, Stephanie J. Lee, Anita D’Souza +8 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

Blood(2020)10.1182/blood.2020006216

N/A

0DataRank · unranked

67 citations

Sarah Nikiforow, Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Marcie Riches +6 more

HLA-B Leader and Survivorship after HLA-Mismatched Unrelated Donor Transplantation

Blood(2020)10.1182/blood.2020005743

N/A

0DataRank · unranked

60 citations

Philip A. Stevenson, Mats Bengtsson, Dianne De Santis, Valérie Dubois, Ted Gooley +11 more

Propranolol inhibits molecular risk markers in HCT recipients: a phase 2 randomized controlled biomarker trial

Blood Advances(2020)10.1182/bloodadvances.2019000765

N/A

0DataRank · unranked

51 citations

J. Douglas Rizzo, Parameswaran Hari, Marcelo C. Pasquini, Karen E. Giles, Anita D’Souza +9 more

Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.027

N/A

0DataRank · unranked

47 citations

Mei-Jie Zhang, Xiao-Ying Tang, Stephanie J. Lee, Ming-Wei Fei, Hai-Lin Wang +14 more

Cancer Moonshot Immuno-Oncology Translational Network (IOTN): accelerating the clinical translation of basic discoveries for improving immunotherapy and immunoprevention of cancer

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000796

N/A

0DataRank · unranked

13 citations

Andrew G. Sikora, Catherine M. Bollard, José R. Conejo-García, Carolina Colli Cruz, Shadmehr Demehri +21 more

Long-term follow-up of BMT CTN 0702 (STaMINA) of postautologous hematopoietic cell transplantation (autoHCT) strategies in the upfront treatment of multiple myeloma (MM).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8506

N/A

0DataRank · unranked

102 citations

Marcelo C. Pasquini, Edward A. Stadtmauer, Raphael Fraser, Mingwei Fei, Steven M. Devine +14 more

Phase II Study of Allogeneic Transplantation for Older Patients With Acute Myeloid Leukemia in First Complete Remission Using a Reduced-Intensity Conditioning Regimen: Results From Cancer and Leukemia Group B 100103 (Alliance for Clinical Trials in Oncology)/Blood and Marrow Transplant Clinical Trial Network 0502

UNC Libraries(2020)10.17615/d8vv-vc17

N/A

0DataRank · unranked

0 citations

William Blum, Flora Mulkey, Richard M. Stone, Shelly Carter, Charles Linker +15 more

Umbilical Cord Blood or HLA-Haploidentical Transplantation: Real-World Outcomes versus Randomized Trial Outcomes

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.11.002

N/A

0DataRank · unranked

24 citations

Claudio G. Brunstein, Ephraim J. Fuchs, Mei‐Jie Zhang, Mariam Allbee-Johnson, Joseph H. Antin +14 more

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2021: Looking Forward as the Network Celebrates its 20th Year

Transplantation and Cellular Therapy(2021)10.1016/j.jtct.2021.08.016

N/A

0DataRank · unranked

18 citations

Edward A. Stadtmauer, John E. Levine, Karen K. Ballen, Yi‐Bin Chen, Amy E. DeZern +20 more

Impact of Changes of the 2020 Consensus Definitions of Invasive Aspergillosis on Clinical Trial Design: Unintended Consequences for Prevention Trials?

Open Forum Infectious Diseases(2021)10.1093/ofid/ofab441

N/A

0DataRank · unranked

5 citations

Barbara D. Alexander, Lindsey R. Baden, Min Chen, Michele W. Sugrue, Helen Leather +10 more

Trajectories of quality of life recovery and symptom burden after autologous hematopoietic cell transplantation in multiple myeloma

American Journal of Hematology(2022)10.1002/ajh.26596

N/A

0DataRank · unranked

30 citations

Ruta Brazauskas, Edward A. Stadtmauer, Marcelo C. Pasquini, Parameswaran Hari, Asad Bashey +16 more

Race and Survival in Unrelated Hematopoietic Cell Transplantation

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.026

N/A

0DataRank · unranked

14 citations

Satoko Morishima, Phil Stevenson, Yoshihisa Kodera, Mary M. Horowitz, Caroline McKallor +5 more

Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.10.016

N/A

0DataRank · unranked

9 citations

Shernan G. Holtan, Akiko Shimamura, Todd Burnworth, Shauna Whisenton, Sanderson Adams +8 more

Impact of Center Experience with Donor Type on Outcomes: A Secondary Analysis, Blood and Marrow Transplant Clinical Trials Network 1101

Transplantation and Cellular Therapy(2022)10.1016/j.jtct.2022.03.024

N/A

0DataRank · unranked

9 citations

Paul V. O’Donnell, Brent R. Logan, Peter Dawson, Luciano J. Costa, Corey Cutler +16 more

Impact of second primary malignancy post-autologous hematopoietic stem cell transplantation on outcomes of multiple myeloma: A CIBMTR analysis.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.8057

N/A

0DataRank · unranked

0 citations

Anita D’Souza, Noel Estrada‐Merly, Raphael Fraser, Gemlyn George, Lohith Gowda +7 more

Incorporating patient-reported outcome data into a hematopoietic cell transplant survival calculator.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7045

N/A

0DataRank · unranked

0 citations

Kathryn E. Flynn, Rachel Cusatis, Anita D’Souza, Betty K. Hamilton, Mary M. Horowitz +5 more

Secondary Neoplasms After Hematopoietic Cell Transplant for Sickle Cell Disease

Journal of Clinical Oncology(2023)10.1200/jco.22.01203

N/A

0DataRank · unranked

55 citations

Ruta Brazauskas, David A. Williams, Mark C. Walters, Andrew St. Martin, Benjamin L. Jacobs +20 more

SARS-CoV-2 vaccination in the first year after allogeneic hematopoietic cell transplant: a prospective, multicentre, observational study

EClinicalMedicine(2023)10.1016/j.eclinm.2023.101983

N/A

0DataRank · unranked

25 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +23 more

Galectin-3 predicts acute GvHD and overall mortality post reduced intensity allo-HCT: a BMT-CTN biorepository study

Bone Marrow Transplantation(2023)10.1038/s41409-023-02168-0

N/A

0DataRank · unranked

9 citations

Kristopher Attwood, Xiaojun Liu, George L. Chen, Hans Minderman, Amin M. Alousi +16 more

How do we improve the translation of new evidence into the practice of hematopoietic cell transplantation and cellular therapy?

Blood Reviews(2023)10.1016/j.blre.2023.101079

N/A

0DataRank · unranked

3 citations

Christopher E. Dandoy, Zachariah DeFilipp, Tamila L. Kindwall‐Keller, Stephen R. Spellman, Celalettin Üstün +7 more

Application of the CIBMTR One Year Survival Outcomes Calculator as a tool for retrospective analysis

Bone Marrow Transplantation(2023)10.1038/s41409-023-02031-2

N/A

0DataRank · unranked

0 citations

Sean M. Devlin, Molly Maloy, Mary M. Horowitz, Brent R. Logan, J. Douglas Rizzo +3 more

SARS-CoV-2 Vaccination in the First Year After Hematopoietic Cell Transplant or Chimeric Antigen Receptor T-Cell Therapy: A Prospective, Multicenter, Observational Study

Clinical Infectious Diseases(2024)10.1093/cid/ciae291

N/A

0DataRank · unranked

25 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +25 more

Long‐term outcomes after unrelated donor transplantation for severe sickle cell disease on the BMT CTN 0601 trial

American Journal of Hematology(2024)10.1002/ajh.27251

N/A

0DataRank · unranked

7 citations

Jianqun Kou, Martin Andreánsky, Monica Bhatia, Joel A. Brochstein, Sonali Chaudhury +15 more

Representativeness of Blood and Marrow Transplant Clinical Trials Network (BMT CTN) Trial Participants

Transplantation and Cellular Therapy(2024)10.1016/j.jtct.2024.10.014

N/A

0DataRank · unranked

7 citations

Mary M. Horowitz, Adam Mendizabal, Min Chen, Amy Foley, Jeffery J. Auletta +3 more

Incorporating patient‐reported outcome data into a predictive calculator for allogeneic hematopoietic cell transplantation recipients

Cancer(2024)10.1002/cncr.35189

N/A

0DataRank · unranked

5 citations

Kathryn E. Flynn, Naya He, Rachel Cusatis, Anita D’Souza, Betty K. Hamilton +6 more

Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102819

N/A

0DataRank · unranked

4 citations

Joseph H. Antin, Jakub Tolar, Sally Arai, Mitchell E. Horwitz, Jianqun Kou +8 more

Tocilizumab not associated with increased infection risk after CAR T-cell therapy: implications for COVID-19?

UNC Libraries(2024)10.17615/h0gs-sd07

N/A

0DataRank · unranked

1 citations

Michael K. Mansour, Zhen‐Huan Hu, Mary M. Horowitz, Peiman Hematti, Miguel‐Angel Perales +6 more

Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial

medRxiv(2024)10.1101/2024.09.16.24313494

N/A

0DataRank · unranked

6 citations

Brent R. Logan, Bronwen E. Shaw, Steven M. Devine, Stefan O. Ciurea, Mary M. Horowitz +23 more

SARS-CoV-2 vaccination in the first year after hematopoietic cell transplant or chimeric antigen receptor T cell therapy: A prospective, multicenter, observational study (BMT CTN 2101)

medRxiv(2024)10.1101/2024.01.24.24301058

N/A

0DataRank · unranked

2 citations

Michael J. Martens, Jo‐Anne H. Young, Kavita V. Bhavsar, Jianqun Kou, Min Chen +25 more

Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial

Transplantation and Cellular Therapy(2025)10.1016/j.jtct.2025.11.010

N/A

0DataRank · unranked

5 citations

Brent R. Logan, Stephanie J. Lee, Bronwen E. Shaw, Steven M. Devine, Stefan O. Ciurea +23 more

Current Use of and Trends in Hematopoietic Cell Transplantation in the United States

Biology of Blood and Marrow Transplantation(2020)10.1016/j.bbmt.2020.04.013

N/A

0DataRank · unranked

707 citations

Caitrin Fretham, Stephanie J. Lee, Mukta Arora, Janet Brunner, Saurabh Chhabra +16 more

Accurate prediction of absolute prokaryotic abundance from DNA concentration

Cell Reports Methods(2025)10.1016/j.crmeth.2025.101030

N/A

0DataRank · unranked

2 citations

Tessa M. Andermann, Erin F. Brooks, Lanya Evans, Adam Groth, Mai Dvorak +23 more

Role of HLA-DP Expression in Graft-Versus-Host Disease After Unrelated Donor Transplantation

Journal of Clinical Oncology(2020)10.1200/jco.20.00265

N/A

0DataRank · unranked

67 citations

Mats Bengtsson, Dianne De Santis, Valérie Dubois, Katharina Fleischhauer, Ted Gooley +13 more